University of Kansas Health System St. Francis Campus, formerly known as St. Francis Health Center is a for-profit hospital in Topeka, Kansas, United States. The hospital was founded in 1909 by the Sisters of Charity of Leavenworth.

There are 378 beds in University of Kansas Health System Saint Francis Campus.

During the past decade, University of Kansas Health System Saint Francis Campus conducted 107 clinical trials. In the 10-year time frame, 107 clinical trials started and 61 clinical trials were completed, i.e. on average, 57% percent of trials that started reached the finish line to date. In the past 5 years, 48 clinical trials started and 37 clinical trials were completed. i.e. 77.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Kansas Health System Saint Francis Campus" #1 sponsor was "National Cancer Institute (NCI)" with 97 trials, followed by "SWOG Cancer Research Network" with 32 trials sponsored, "Alliance for Clinical Trials in Oncology" with 11 trials sponsored, "NRG Oncology" with 8 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 8 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Kansas Health System Saint Francis Campus" #1 collaborator was "National Cancer Institute (NCI)" with 62 trials as a collaborator, "Canadian Cancer Trials Group" with 9 trials as a collaborator, "NRG Oncology" with 9 trials as a collaborator, "Cancer and Leukemia Group B" with 7 trials as a collaborator and "NCIC Clinical Trials Group" with 6 trials as a collaborator. Other collaborators include 27 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "University of Kansas Health System Saint Francis Campus" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Lung Cancer AJCC v8" (9 trials), "Invasive Breast Carcinoma" (7 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials) and "Recurrent Breast Carcinoma" (6 trials). Many other conditions were trialed in "University of Kansas Health System Saint Francis Campus" in a lesser frequency.

Most popular intervention types in "University of Kansas Health System Saint Francis Campus" are "Drug" (132 trials), "Other" (100 trials), "Biological" (76 trials), "Procedure" (46 trials) and "Radiation" (23 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (53 trials), "Quality-of-Life Assessment" (37 trials), "Biospecimen Collection" (30 trials), "Computed Tomography" (26 trials) and "Questionnaire Administration" (24 trials). Other intervention names were less common.

The vast majority of trials in "University of Kansas Health System Saint Francis Campus" are 137 trials for "All" genders, 16 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "University of Kansas Health System Saint Francis Campus". undefined are not yet recruiting, 38 are recruiting, 85 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 27 completed trials in University of Kansas Health System Saint Francis Campus, 4 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in University of Kansas Health System Saint Francis Campus, 11 "Phase 1" clinical trials were conducted, 86 "Phase 2" clinical trials and 76 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".

University of Kansas Health System Saint Francis Campus has several departments that took part in Clinical trials: "St. Francis Comprehensive Cancer Center" - 38 trials